Buck Kristen K 4
4 · LISATA THERAPEUTICS, INC. · Filed Sep 5, 2023
Insider Transaction Report
Form 4
Buck Kristen K
EVP, R&D and CMO
Transactions
- Tax Payment
Common Stock
2023-09-01$2.18/sh−2,908$6,339→ 32,915 total
Footnotes (2)
- [F1]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F2]Includes 15,650 unvested restricted stock awards.